Gen Lin
Fujian Medical University
54 Papers
52 Citations
Gen Lin is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 6, co-authored 25 publications.
Chat about Author
Papers
Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer.
Haipeng Xu,Gen Lin,Cheng Huang,Weifeng Zhu,Qian Miao,Xirong Fan,Biao Wu,Xiaobing Zheng,Xiandong Lin,Kan Jiang,Dan Hu,Chao Li +11 more
TL;DR: The data suggest that the use of different reagents may account for inconsistencies in the literature regarding the association between PD-L1 expression and clinicopathological features, and that the results from the two assays cannot be interchanged.
Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer.
Chunwei Xu,Wen-Xian Wang,Mei-juan Wu,You-cai Zhu,Wu Zhuang,Gen Lin,Kai-qi Du,Yun-jian Huang,Yanping Chen,Gang Chen,Mei-yu Fang +10 more
TL;DR: This work detected the consistency of c‐MET gene amplification in metastatic lymph nodes and tumor tissues of NSCLC patients and discusses the clinical application value of c-MET gene Amplification in metastasis lymph nodes.
19
Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis
TL;DR: IP-based multimodal therapy has significant efficacy and a controlled safety profile in patients with rLM in NCSLC and OS was not mature at the final follow-up.
The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer
Hanxiao Chen,Dingzhi Huang,Gen Lin,Xue Yang,Minglei Zhuo,Yujia Chi,Xiaoyu Zhai,Bo Jia,Jingjing Wang,Yuyan Wang,Jianjie Li,Tongtong An,Meina Wu,Ziping Wang,Jun Zhao +14 more
TL;DR: Assessment of real‐world data of Chinese patients with KRAS‐mutant NSCLC undergoing chemotherapy and/or immunotherapy of Kirsten rat sarcoma viral oncogene homolog found no significant differences in survival rates.
15
KRAS mutation and NF-κB activation indicates tolerance of chemotherapy and poor prognosis in colorectal cancer.
TL;DR: NF-κB activation was associated with KRAS mutation, and bothKRAS mutation and NF-κb activation were indicative of high tolerance of chemotherapy and poor prognosis for colorectal cancer patients.
15